Explore the significance of new cannabis research insights published in Drug and Alcohol Dependence. This article highlights ...
Research suggests that people who stop taking GLP-1 medications such as Ozempic, Wegovy and similar products are likely to ...
'Doctors and patients should be aware.' ...
Dr. Kim Schmidt takes an integrative approach to pet care with a focus on natural treatments through a unique telehealth ...
Millions of people use GLP-1 medicines.
Psychedelics in mental health treatment is a rapidly changing landscape, but it is important for primary care providers to ...
A first-of-its-kind pilot program in Utah developed by a health-technology startup company uses artificial intelligence to ...
Indiana Gov. Mike Braun considers legalizing marijuana as surrounding states have done. Feds reschedule medical marijuana, ...
Older adults with type 2 diabetes face a difficult trade-off: they are among the most vulnerable to medication-related harms ...
The DOJ is loosening federal regulations on medicinal marijuana, moving it from Schedule I to Schedule III, allowing tax ...
Could drugs like Mounjaro treat people with cannabis use disorder? They might. Preliminary research indicates they may stop ...
For the past 15 years, Gerald W. Smetana, MD, MACP, from Harvard Medical School, has given a presentation at the ACP Internal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results